AD-induced amyloidosis causes release of fractalkine (CX3CL1) from neurons, which by stimulating its receptor CX3CR1 that is present on microglia and several leukocyte types, promotes neural and vascular inflammation and reduced eNOS and nitric oxide (NO) [4, 5, 68–70]. The gene discussed is CX3CR1; the disease is Alzheimer disease.